Neurogene (NGNE) Capital Leases (2015 - 2026)

Neurogene (NGNE) posted Capital Leases of $4000.0 for Q1 2026, down 20.0% on a QoQ basis from $5000.0 in Q4 2025, and down 76.47% year-over-year from $17000.0 in Q1 2025.

Neurogene (NGNE) Capital Leases (2015 - 2026) Analysis & Trends

Neurogene's Capital Leases history runs 12 years deep, the most recent figure standing at $4000.0 for Q1 2026.

  • Quarterly Capital Leases fell 76.47% year-over-year to $4000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4000.0 (down 76.47% YoY) and the FY2025 annual result came in at $5000.0, down 80.77% from the prior year.
  • Capital Leases was $4000.0 for Q1 2026 at Neurogene, down from $5000.0 in the prior quarter.
  • Across five years, Capital Leases topped out at $66000.0 in Q1 2022 and bottomed at $4000.0 in Q1 2026.
  • A 5-year average of $26294.1 and a median of $10000.0 in 2022 frame the typical range for Capital Leases.
  • Annual changes were most pronounced in 2023 — Capital Leases plunged 89.39% — and 2024, when it jumped 783.33%.
  • Neurogene's Capital Leases stood at $66000.0 in 2022, then fell by 1.52% to $65000.0 in 2023, then plunged by 60.0% to $26000.0 in 2024, then slumped by 80.77% to $5000.0 in 2025, then declined by 20.0% to $4000.0 in 2026.
  • Business Quant data shows NGNE's Capital Leases at $4000.0 in Q1 2026, $5000.0 in Q4 2025, and $7000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Neurogene 17.50 Mn 17.50 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 4,000.00
Dec 31, 2025 5,000.00
Sep 30, 2025 7,000.00
Jun 30, 2025 9,000.00
Mar 31, 2025 17,000.00
Dec 31, 2024 26,000.00
Sep 30, 2024 39,000.00
Jun 30, 2024 53,000.00
Mar 31, 2024 53,000.00
Dec 31, 2023 65,000.00
Sep 30, 2023 5,000.00
Jun 30, 2023 6,000.00
Mar 31, 2023 7,000.00
Dec 31, 2022 66,000.00
Sep 30, 2022 9,000.00
Jun 30, 2022 10,000.00
Mar 31, 2022 66,000.00
Dec 31, 2021 67,000.00
Sep 30, 2021 68,000.00
Jun 30, 2021 68,000.00